Related Experiment Video
Updated: Oct 17, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long noncoding RNAs: fine-tuners hidden in the cancer signaling network
Shanshan Zhao1, Xue Zhang2, Shuo Chen3
1Key Laboratory of Reproductive Dysfunction Diseases and Fertility Remodeling of Liaoning Province, Reproductive Medicine Center, Obstetrics and Gynecology Department, Shengjing Hospital Affiliated to China Medical University, 110022, Shenyang, Liaoning, China.
Abstract:
With the development of sequencing technology, a large number of long non-coding RNAs (lncRNAs) have been identified in addition to coding genes. LncRNAs, originally considered as junk RNA, are dysregulated in various types of cancer. Although protein-coding signaling pathways underlie various biological activities, and abnormal signal transduction is a key trigger and indicator for tumorigenesis and cancer progression, lncRNAs are sparking keen interest due to their versatile roles in fine-tuning signaling pathways. We are just beginning to scratch the surface of lncRNAs. Therefore, despite the fact that lncRNAs drive malignant phenotypes from multiple perspectives, in this review, we focus on important signaling pathways modulated by lncRNAs in cancer to demonstrate an up-to-date understanding of this emerging field.
Insights
Long non-coding RNAs (lncRNAs) are increasingly recognized for their role in cancer by fine-tuning critical signaling pathways. This review highlights key lncRNA-modulated pathways driving cancer progression.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (lncRNAs) were once dismissed as "junk RNA" but are now known to be crucial regulators in biological processes.
- Dysregulation of lncRNAs is frequently observed in various cancers, impacting disease initiation and progression.
- Signaling pathways are fundamental to cellular activities, and their aberrant transduction is a hallmark of cancer.
Purpose of the Study:
- To review the current understanding of how long non-coding RNAs (lncRNAs) modulate key signaling pathways in cancer.
- To highlight the versatile roles of lncRNAs in fine-tuning oncogenic signaling.
- To provide an up-to-date perspective on lncRNAs in cancer biology.
Main Methods:
- Literature review focusing on peer-reviewed research articles.
- Analysis of studies investigating the functional roles of lncRNAs in cancer-related signaling pathways.
- Synthesis of findings on lncRNA involvement in tumorigenesis and cancer progression.
Main Results:
- lncRNAs play significant roles in regulating multiple cancer-associated signaling pathways.
- These lncRNAs can act as oncogenes or tumor suppressors by modulating signal transduction.
- Emerging evidence indicates lncRNAs are critical drivers of malignant phenotypes.
Conclusions:
- lncRNAs are vital regulators of signaling pathways implicated in cancer.
- Further research into lncRNA functions is essential for understanding cancer development and for therapeutic strategies.
- lncRNAs represent a promising area for novel cancer diagnostics and therapeutics.
Related Concept Videos
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
Types of RNA
RNA Performs Diverse...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
